Finding:

1. close

   Graft-versus-host disease

   Graft-versus-host disease (GVHD) is a common complication of allogeneic bone marrow transplantation in which functional immune cells in the transplanted marrow recognize the recipient as "foreign" and mount an immunologic attack.
2. close

   Hematopoietic stem cell transplantation

   Even if there is a good match at these critical alleles, the recipient will require immunosuppressive medications to mitigate graft-versus-host disease.
3. close

   Stem cell transplantation

   Acute graft-versus-host disease typically occurs in the first three months after transplantation and may involve the skin, intestine, or the liver.
4. close

   Transfusion-associated graft versus host disease

   | Transfusion-associated graft versus host disease Classification and external resources | ... Complications of surgical and medical care
5. close

   Transplant rejection

   There is a risk of graft versus host disease (GVHD) in which the lymphoid cells co-injected with the bone marrow transplant recognize the host tissues as foreign and attack and destroy them accordingly.
6. close

   Palmar plantar erythrodysesthesia

   As time progresses, patients with graft-versus-host disease progress to have other body parts affected, while PPE is limited to hands and feet.
7. close

   Bone grafting

   Graft-versus-host disease
8. close

   History and naming of human leukocyte antigens

   Further information: Graft-versus-host disease
9. close

   Coeliac disease

   Contact dermatitis · Mantoux test · Graft-versus-host disease
10. close

    Hairy cell leukemia

    Blood transfusions are always irradiated to remove white blood cells and thereby reduce the risk of graft-versus-host disease.

Explore the following pages on Powerset:

• Graft-versus-host disease,
• Hematopoietic stem cell transplantation,
• Stem cell transplantation,
• Transfusion-associated graft versus host disease,
• Transplant rejection,
• Palmar plantar erythrodysesthesia,
• Bone grafting,
• History and naming of human leukocyte antigens,
• Coeliac disease,
• Hairy cell leukemia